Fisher & Paykel Healthcare Corporation Limited, operating with its various subsidiaries, is a global innovator in medical device technology. The company specializes in the design, production, and worldwide distribution of sophisticated products and systems. These solutions primarily cater to acute and chronic respiratory care, support during surgical procedures, and the treatment of obstructive sleep apnea (OSA) in both clinical settings and home environments. Their product lineup includes notable items such as the Airvo 2, a humidified nasal high flow system; Optiflow, designed for nasal high flow therapy; and the F&P 850 System, which offers both non-invasive and invasive ventilation capabilities. For infant care, the company supplies respiratory products used in resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy. Hospital-grade offerings comprise humidification devices, breathing circuits, chambers, diverse masks, nasal cannulas, surgical accessories, and various interfaces. For homecare users, Fisher & Paykel provides masks, CPAP devices, data management software, humidifiers, and complementary accessories. Established in 1934, the company maintains its headquarters in Auckland, New Zealand.
Subscribe to see FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED is a health care equipment & services company headquartered in Auckland, New Zealand. Xcout tracks 9 named people at FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED, including Daniel Hedigan (President & Chief Executive Officer).
3 more named people on record for FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED, with roles, board committees and tenure — see the full roster →
A few of FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED's closest competitors — see the full list of competitors and alternatives →
ResMed Inc. is a medical equipment company headquartered in San Diego, California, originally founded in Australia. It primarily provides cloud-connectable medical devices for the healthcare market.
Compumedics Limited is a global medical technology enterprise engaged in the full lifecycle of designing, producing, marketing, and distributing advanced diagnostic medical devices. Its market reach extends across Australia, the Asia Pacific region, the Americas, Europe, and the Middle East. The company's product portfolio is primarily focused on solutions for sleep and neurological disorders. For sleep diagnostics, offerings include sophisticated PSG:EEG amplification systems like the Grael 4K, portable recording units such as the Somté PSG and Siesta 802, wearable monitoring devices like Somfit/Somfit Pro, and transcutaneous monitors (e.g., TCM5 FLEX). In the field of neurology, Compumedics supplies devices like the ONsight A.V.S. for home ambulatory studies, a variety of EEG amplifiers (e.g., Grael 4K-EEG, Grael LT EEG), comprehensive long-term EEG monitoring systems (Neuvo 64-512 Channel LTM), and specialized EMG/EP systems (including Xegis Forte and Xegis G:NEO). Complementing its hardware, the company develops an extensive range of software, featuring the Profusion Sleep and EEG platforms, Profusion neXus 360 (a web-based system for patient data and lab management), a Multi-Modal Neuroimaging Suite, and workflow optimization tools like Profusion neXus Laboratory Management and Scheduler. Other software offerings include HD Digital Video integration and various specialized applications. Furthermore, Compumedics provides magnetoencephalography systems, cutting-edge brain research technologies, services for pharmaceutical clinical trials and research, as well as a diverse array of accessories and consumables crucial for diagnostic and research endeavors. Established in 1987, Compumedics Limited is based in Abbotsford, Australia, and functions as a subsidiary of D & DJ Burton Holdings Pty Ltd.
Based in Melbourne, Australia, Respiri Limited operates as an e-health software-as-a-service (SaaS) provider. The company is dedicated to the research, development, and commercialization of medical devices across Australia, and also creates, manufactures, and distributes mobile health applications. Its key offerings include wheezo, an innovative electronic tool specifically designed for identifying wheezing in children, along with the Respiri mobile application and the Respiri health portal. The organization officially became Respiri Limited in December 2015, having previously conducted business as iSonea Limited.
CardieX Limited, established in Sydney, Australia, in 1994, is a global innovator specializing in the design, production, and distribution of medical devices for cardiovascular health management. Operating across the Americas, Europe, and the Asia Pacific, the company collaborates with pharmaceutical firms by providing its advanced SphygmoCor XCEL devices. It also delivers comprehensive laboratory and data management services, ensuring high-quality datasets for clinical trial sponsors. Under its CONNEQT brand, CardieX develops cutting-edge home vascular health solutions, which encompass remote patient monitoring, tools for decentralized clinical trials, specialized wearables, and medical applications. A flagship product is the CONNEQT Pulse device, a home-based system that leverages proprietary SphygmoCor technology to precisely measure central blood pressure, arterial waveforms, and other vital arterial health parameters. CardieX serves a diverse clientele, including hospitals, clinics, research institutions, and pharmaceutical companies. The company also maintains a strategic alliance with LifeQ, Inc., focusing on wearable device technology. CardieX Limited was formerly known as AtCor Medical Holdings Limited until its name change in June 2018.
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
CAIRE Health Holdings, Inc. manufactures and supplies medical oxygen therapy equipment, including portable and stationary oxygen concentrators, liquid oxygen systems, and onsite gas generators. The company also provides cardiorespiratory diagnostics devices to healthcare providers, patients, and commercial applications.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.